NCLEX-style practice question
A nurse is caring for a client with Alzheimer disease who is prescribed donepezil. The client's family asks whether this medication will stop the progression of the disease. Which response by the nurse is most accurate?
- The medication stops the buildup of beta-amyloid plaques in the brain.
- The medication will slow the disease course over several years.
- The medication treats cognitive symptoms but does not change the underlying disease process.
- The medication reverses the brain cell loss that has already occurred.
Show answer and rationale
Correct answer: C. The medication treats cognitive symptoms but does not change the underlying disease process.
Donepezil is a cholinesterase inhibitor that affects neurotransmitter levels to manage cognitive symptoms but does not alter the underlying brain changes or slow disease progression. The beta-amyloid-targeting drugs such as lecanemab are the ones associated with slowing decline, so the family's expectation of stopping progression is incorrect.
Adapted from Nursing Fundamentals 2e.
Category: Pharmacological and Parenteral Therapies / Pharmacological Therapies